Atlas Trials

Platform Trial in Stage 1 Diabetes: Comparing Golimumab vs Placebo

Clinical trial NCT07683026 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07683026
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Type 1 Diabetes (T1D)
Start date
2026-08-08
Primary completion
2032-09-01
Enrollment
255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.